Twist Bioscience Corp. (TWST)
111.56
-2.66
(-2.33%)
USD |
NASDAQ |
Nov 13, 16:00
110.49
-1.07
(-0.96%)
After-Hours: 19:59
Twist Bioscience Market Cap : 6.992B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 7.159B |
| November 11, 2026 | 7.683B |
| November 10, 2026 | 8.281B |
| November 09, 2026 | 8.482B |
| November 06, 2026 | 7.570B |
| November 05, 2026 | 7.559B |
| November 04, 2026 | 8.936B |
| November 03, 2026 | 8.793B |
| November 02, 2026 | 8.087B |
| October 30, 2026 | 9.575B |
| October 29, 2026 | 10.87B |
| October 28, 2026 | 10.87B |
| October 27, 2026 | 10.02B |
| October 26, 2026 | 9.103B |
| October 23, 2026 | 8.769B |
| October 22, 2026 | 8.490B |
| October 21, 2026 | 9.347B |
| October 20, 2026 | 8.944B |
| October 19, 2026 | 8.760B |
| October 16, 2026 | 8.320B |
| October 15, 2026 | 9.056B |
| October 14, 2026 | 9.286B |
| October 13, 2026 | 9.484B |
| October 12, 2026 | 9.518B |
| October 09, 2026 | 10.01B |
| Date | Value |
|---|---|
| October 08, 2026 | 9.530B |
| October 07, 2026 | 9.755B |
| October 06, 2026 | 10.46B |
| October 05, 2026 | 12.85B |
| October 02, 2026 | 11.82B |
| October 01, 2026 | 11.79B |
| September 30, 2026 | 12.11B |
| September 29, 2026 | 11.67B |
| September 28, 2026 | 11.26B |
| September 25, 2026 | 11.46B |
| September 24, 2026 | 11.53B |
| September 23, 2026 | 9.934B |
| September 22, 2026 | 10.32B |
| September 21, 2026 | 10.39B |
| September 18, 2026 | 10.47B |
| September 17, 2026 | 9.750B |
| September 16, 2026 | 8.967B |
| September 15, 2026 | 8.655B |
| September 14, 2026 | 8.445B |
| September 11, 2026 | 7.973B |
| September 10, 2026 | 7.950B |
| September 09, 2026 | 7.867B |
| September 08, 2026 | 8.026B |
| September 04, 2026 | 7.817B |
| September 03, 2026 | 8.067B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.361B |
| Beam Therapeutics, Inc. | 2.364B |
| 10X Genomics, Inc. | 7.650B |
| Moderna, Inc. | 90.17B |
| Prime Medicine, Inc. | 769.04M |
Market Cap Related Metrics
| PS Ratio | 15.86 |
| PEG Ratio | -0.9434 |
| Price to Book Value | 15.69 |
| Price | 111.56 |
| Earnings Yield | -1.59% |
| PEGY Ratio | -0.9434 |